Tag: radiopharmaceutical
Telix to acquire ITM in US$1.65 billion radiopharmaceutical deal
Telix Pharmaceuticals has announced plans to acquire German radiopharmaceutical company ITM Isotope Technologies Munich SE for US$1.65 billion, in a transaction the company says will expand its capabilities across the radiopharmaceutical value chain.
Clarity and Nucleus RadioPharma scale up manufacturing for cancer treatment
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has entered into a Master Services Agreement (MSA) and Clinical Manufacturing Agreement for the production of 67Cu-SAR-bisPSMA, a radiopharmaceutical treatment for prostate cancer.
Australian pharma firm Telix opens $21m radiopharmaceutical production facility in Belgium
ASX-listed Telix Pharmaceuticals has recently opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility in Belgium, serving as the primary manufacturing site for radioisotopes and commercial and clinical products for patients in the Europe Middle East and Africa (EMEA) region.
















